Could more seizure-free days be in your future?

About the Power1 Study

The Power1 study is a clinical research study conducted in accordance with regulatory and health authority requirements. It evaluates vormatrigine, an investigational medication, as a potential treatment for focal onset seizures in adults. The study is sponsored by Praxis Precision Medicines.

Who can participate in this study?

Be 18 to 75 years old
Currently experience seizures
Take 1 to 3 antiseizure medications

Additional criteria will be assessed at screening.

Will the study have any cost?

All travel expenses and any other costs associated with the study will be covered by the sponsor. This includes taxi or rideshare to and from the study office if you are unable to drive. No insurance is required to participate.

Why participate?

All study-related care at no cost, with the flexibility of some visits conducted at your home
Close monitoring by an experienced doctor and study staff who understand epilepsy
The opportunity to advance medical knowledge and potentially help others living with epilepsy
Your safety is the highest priority throughout the study — a direct contact will always be available if you have questions or concerns
Your participation is completely voluntary — you may withdraw at any time and for any reason
Your privacy will be maintained throughout the entire study

You may complete most study visits from home.

Apply to Participate in an Ongoing Clinical Trial:

Could more seizure-free days be in your future?

About the Power1 Study

Who can participate in this study?

Will the study have any cost?

Why participate?

Connect With Us: